Activin-ACTRIIA antagonist and the purposes in treatment or Breast Cancer Prevention

Activin-ACTRIIA antagonist and the purposes in treatment or Breast Cancer Prevention

  • CN 101,835,485 B
  • Filed: 02/01/2008
  • Issued: 10/26/2016
  • Est. Priority Date: 02/01/2007
  • Status: Active Grant
First Claim
Patent Images

1. ActRIIa-Fc fusion protein is used for treating in patient or preventing the medicine of estrogen receptor negative breast carcinoma in preparationPurposes in thing, wherein said ActRIIa-Fc fusion protein is the polypeptide being made up of the aminoacid sequence of SEQ ID NO:

  • 7.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×